Last news
VCI Global Announces 1-for-20 Reverse Stock Split

VCI Global Announces 1-for-20 Reverse Stock Split

Notified -...

AI-Media Partners with AudioShake to Revolutionize Live Sports Audio and AI Voice Translation

AI-Media Partners with AudioShake to Revolutionize Live Sports Audio and AI Voice Translation

Notified -...

Vicor to present at WCX 2025 in Detroit

Vicor to present at WCX 2025 in Detroit

Notified -...

YY Group Strengthens Leadership Team with Alvin Low as Head of Integrated Facility Management Division

YY Group Strengthens Leadership Team with Alvin Low as Head of Integrated Facility Management Division

[img]http://phpstack-1214942-4313335.cloudwaysapps.com/api/ImageRender/DownloadFile?resourceId=42ce1a26-463d-45d7-97ec-d5fa10439b68&size=3[/img]Notified -...

Anaqua Announces Leadership Change in Japan and the Broader Asia-Pacific Region

Anaqua Announces Leadership Change in Japan and the Broader Asia-Pacific Region

Notified -...

Nexif Ratch Energy Secures Pre-Development ECC for San Miguel Bay Wind Power Project in the Philippines

Nexif Ratch Energy Secures Pre-Development ECC for San Miguel Bay Wind Power Project in the Philippines

Notified -...

Picus Security Announces Recognition in Gartner® Market Guide for Adversarial Exposure Validation

Picus Security Announces Recognition in Gartner® Market Guide for Adversarial Exposure Validation

Notified -...

New Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable

New Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable

Notified -...

1 2 3 4 5 6 7 8 9 10 ... 753
menu
menu